Custom CRISPR sgRNA Non-Viral Vectors

abm offers Custom All-in-One (Cas9 and sgRNA expression) and sgRNA-only expressing Non-Viral Vectors that will simplify and streamline your CRISPR/Cas9 experiment. Choose from our All-in-One system or our sgRNA-only expression system and pair the latter with a Cas9-Expressing Stable Cell Line or spCas9 Nuclease. Inquire with us below to get started on your custom CRISPR project.

A non-viral vector from abm is the simplest approach to deliver sgRNAs into cells, ideal for expressing sgRNAs in a transient manner to limit off-target effects. When the non-viral vector has done its work, it can be diluted out of the cell population by passaging the cells and monitoring the GFP fluorescence until it is gone.  




Service Details

Service  Vector Unit Cat. No. Price
Custom CRISPR sgRNA Non-Viral Vector (for spCas9) – single target pNV-sgRNA-GFP 1.0 µg C439 $135.00
Custom CRISPR sgRNA Non-Viral Vector (for spCas9) – set of three targets pNV-sgRNA-GFP 3 x 1.0 µg C443 $360.00
Custom CRISPR All-in-One Non-Viral Vector (with spCas9) – single target pNV-sgRNA-Cas9-2A-GFP 1.0 µg C440 $125.00
Custom CRISPR All-in-One Non-Viral Vector(with spCas9) – set of three targets pNV-sgRNA-Cas9-2A-GFP 3 x 1.0 µg C444 $355.00

Additional Info

Workflow

Available Custom CRISPR Vectors & Viruses

AAV Vector
/Virus
Lentivector
/Virus
Non-Viral
Vector
Adenovirus
sgRNA for spCas9 Available Available Available Available
sgRNA for saCas9 Available - - -
All-in-One with spCas9 - Available Available -
All-in-One with saCas9 Available - - -
All-in-One with FnCas12a (FnCpf1) - Available - -
Browse Collection Browse Collection Browse Collection Browse Collection

Additional Resources


Citations

01 Kang, Y. J. et al. "Regulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling." Nat. Commun. (2015) 6:8371 doi: 10.1038/ncomms9371
02 Jiang, G. et al. "Isorhapontigenin (ISO) inhibits invasive bladder cancer (BC) formation in vivo and human BC invasion in vitro by targeting STAT1/FOXO1 Axis." Cancer Prev Res. Published Online First April 14, 2016.doi: 10.1158/1940-6207.CAPR-15-0338
03 Okugawa, Y. et al. "Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer." Gut (2015)doi:10.1136/gutjnl-2015-309359